Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: Clin Cancer Res. 2021 Oct 1;27(19):5353–5364. doi: 10.1158/1078-0432.CCR-20-4641

Figure 6. Staining of kidney and colon samples of patients with immune-checkpoint inhibitor associated nephritis and colitis reveal presence of granzyme B.

Figure 6.

A) Immunofluorescence staining against Granzyme B (red) of a control and 4 kidney samples of clinical patients with immune-checkpoint inhibitor associated nephritis. B) Immunofluorescence staining against Granzyme B (red) of colon samples of clinical patients with (patients 1–3) and without (control) immune-checkpoint inhibitor associated colitis. Nuclei is stained with DAPI (blue).